| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.0009 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |